OSN [Ossen Innovation] 20-F/A: (Original Filing)

[OSSEN INNOVATION CO., LTD. FORM 20-F ANNUAL REPORT EXPLANATORY NOTE For the convenience of the reader, the Amendment sets forth the Original Filing in its entirety, except that the following items and sections in the Original Filing have been amended: · The paragraph under the heading “Technical After-Sales Services” in Item 4B. · The penultimate paragraph under the heading “Revenue] [List of Subsidiaries of Ossen Innovation Co. Ltd. Name Country of Incorporation Ossen Innovation Materials Group Co., Ltd. British Virgin Islands Ossen Group (Asia) Co., Ltd. British Virgin Islands Topchina Development Group Ltd. British Virgin Islands Ossen Innovation Materials Co. Ltd. People’s Republic of China Ossen (Jiujiang) New Materials Co., Ltd. People’s Republic of China] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Wei Hua, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Feng Peng, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [1. 2. Wei Hua] [1. 2. Feng Peng (Principal Financial Officer)]

OSN [Ossen Innovation] 20-F/A: OSSEN INNOVATION CO., LTD. FORM 20-F ANNUAL REPORT

[OSSEN INNOVATION CO., LTD. FORM 20-F ANNUAL REPORT EXPLANATORY NOTE For the convenience of the reader, the Amendment sets forth the Original Filing in its entirety, except that the following items and sections in the Original Filing have been amended: · The paragraph under the heading “Technical After-Sales Services” in Item 4B. · The penultimate paragraph under the heading “Revenue] [List of Subsidiaries of Ossen Innovation Co. Ltd. Name Country of Incorporation Ossen Innovation Materials Group Co., Ltd. British Virgin Islands Ossen Group (Asia) Co., Ltd. British Virgin Islands Topchina Development Group Ltd. British Virgin Islands Ossen Innovation Materials Co. Ltd. People’s Republic of China Ossen (Jiujiang) New Materials Co., Ltd. People’s Republic of China] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Wei Hua, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [EXCHANGE ACT RULE 13A-14(A)/15D-14(A) OF THE SARBANES-OXLEY ACT OF 2002 I, Feng Peng, certify that: 1. I have reviewed this annual report on Form 20-F/A of Ossen Innovation Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [1. 2. Wei Hua] [1. 2. Feng Peng (Principal Financial Officer)]

WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR September 23, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life Science Limited, WuXi Merger]

By | 2016-03-24T02:05:43+00:00 September 23rd, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T02:08:32+00:00 September 23rd, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Skip to toolbar